載入...
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
BACKGROUND: Fibulin-3 is a new potential biomarker for malignant mesothelioma (MM). This study evaluated the potential applicability of fibulin-3 plasma levels as a biomarker of response to treatment and its prognostic value for progressive disease within 18 months. The potential applicability of fi...
Na minha lista:
| 發表在: | Radiol Oncol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Versita, Warsaw
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4577225/ https://ncbi.nlm.nih.gov/pubmed/26401134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/raon-2015-0019 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|